IRIS
CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.041
AS - Asia 1.443
EU - Europa 1.013
SA - Sud America 179
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 1
Totale 4.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.967
SG - Singapore 534
CN - Cina 417
VN - Vietnam 219
DE - Germania 208
SE - Svezia 193
IE - Irlanda 182
BR - Brasile 125
IT - Italia 119
FI - Finlandia 85
HK - Hong Kong 72
FR - Francia 51
ZA - Sudafrica 50
TR - Turchia 41
NL - Olanda 40
CA - Canada 39
BD - Bangladesh 32
GB - Regno Unito 31
IN - India 29
RU - Federazione Russa 24
CI - Costa d'Avorio 21
AR - Argentina 16
BE - Belgio 15
MX - Messico 15
EC - Ecuador 13
IQ - Iraq 13
IR - Iran 12
PL - Polonia 11
ES - Italia 10
PK - Pakistan 10
ID - Indonesia 8
LT - Lituania 8
CO - Colombia 7
UZ - Uzbekistan 7
AT - Austria 6
EU - Europa 6
TH - Thailandia 6
CL - Cile 5
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
HU - Ungheria 4
JP - Giappone 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
TW - Taiwan 4
VE - Venezuela 4
BB - Barbados 3
CR - Costa Rica 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
MA - Marocco 3
MY - Malesia 3
PT - Portogallo 3
RO - Romania 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KR - Corea 2
LV - Lettonia 2
PE - Perù 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
TN - Tunisia 1
UA - Ucraina 1
UY - Uruguay 1
Totale 4.769
Salva come PNG Salva come JPEG
Città #
Ashburn 329
Chandler 302
Singapore 285
Santa Clara 186
Dublin 169
Munich 161
San Jose 144
Beijing 81
Ho Chi Minh City 72
Hong Kong 71
Boardman 63
Helsinki 63
Nanjing 59
Dearborn 55
Los Angeles 55
Shanghai 51
Johannesburg 46
Hanoi 45
Dallas 43
New York 42
Council Bluffs 37
Princeton 30
Izmir 28
Lauterbourg 26
Frankfurt am Main 24
Ann Arbor 23
Buffalo 23
Parma 22
Abidjan 21
Turku 20
Wilmington 17
Moscow 15
Toronto 15
Brussels 14
Hefei 14
Phoenix 14
Pune 14
San Mateo 14
São Paulo 14
Nanchang 13
Shenyang 13
Tianjin 13
London 12
Changsha 11
Montreal 10
Boston 9
Kunming 9
Orem 9
Haiphong 8
Jiaxing 8
Jinan 8
Can Tho 7
Columbus 7
Da Nang 7
Hải Dương 7
Norwalk 7
Hangzhou 6
Houston 6
Kocaeli 6
Rome 6
Warsaw 6
Bremen 5
Chengdu 5
Chennai 5
Curitiba 5
Guangzhou 5
Hebei 5
Lahore 5
Menlo Park 5
Milan 5
Quito 5
Seattle 5
Tashkent 5
Thái Bình 5
Zanjan 5
Augusta 4
Baghdad 4
Brooklyn 4
Cambridge 4
Denver 4
Long Beach 4
Mexico City 4
Ningbo 4
Nuremberg 4
Olomouc 4
Thái Nguyên 4
Tokyo 4
Andover 3
Atlanta 3
Bangkok 3
Bishkek 3
Biên Hòa 3
Bridgetown 3
Bình Phước 3
Charlotte 3
Chicago 3
Erbil 3
Frattamaggiore 3
Grafing 3
Las Vegas 3
Totale 3.052
Salva come PNG Salva come JPEG
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 301
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 264
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 188
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 174
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 171
Does chronic hypercalcemia influence serum pepsinogens levels? 162
Gastro panel® for detection of atrophic gastritis: The “Parma model” 160
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 158
Serum pepsinogen II for early assessment of success of H. pylori eradication 157
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 156
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 152
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 149
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 148
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 147
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 145
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 145
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 144
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 144
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 144
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 143
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 139
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 137
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 136
Cancro gastrico e Helicobacter pylori 136
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 134
A new curcumin-based one week therapy for eradication of H. pylori infection 127
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 125
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 124
La diagnosi sierologica delle gastriti croniche atrofiche 123
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 120
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 117
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 45
Totale 4.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 0 29 6 12 11 10 15 32 66
2022/2023784 65 95 71 83 55 97 4 63 215 4 30 2
2023/2024263 11 19 5 6 21 63 21 31 9 15 33 29
2024/20251.036 36 36 40 55 115 130 56 61 173 67 89 178
2025/20261.754 223 112 145 200 264 123 141 50 220 169 65 42
2026/2027307 35 82 85 101 4 0 0 0 0 0 0 0
Totale 4.815